KEGG   DRUG: Mecbotamab vedotin
Entry
D12220                      Drug                                   
Name
Mecbotamab vedotin
Efficacy
Antineoplastic
  Type
Antibody-drug conjugate
Comment
Treatment of cancers expressing the AXL transmembrane receptor protein
Target
  Pathway
hsa01521  EGFR tyrosine kinase inhibitor resistance
Brite
Target-based classification of drugs [BR:br08310]
 Protein kinases
  Receptor tyrosine kinases (RTK)
   AXL family
    AXL
     D12220  Mecbotamab vedotin
 Not elsewhere classified
  Cellular process
   Cytoskeleton
    TUBB
     D12220  Mecbotamab vedotin
Other DBs
CAS: 2460400-64-8
PubChem: 497620633
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system